Key Facts

As a leader in the Canadian biotech pharmaceutical industry, EMD Serono, Canada, is driven to improve the quality of people’s lives through the integration of cutting-edge science with state-of-the-art patient support.
EMD Serono, Canada, has grown to employ over 150 people across many disciplines including, sales and marketing, medical and regulatory affairs, drug safety, quality assurance, process development, market access, compliance, and patient services.
EMD Serono, Canada’s, role as a cornerstone of the Canadian biotech pharmaceutical industry since 1990 is demonstrated by the following achievements:
  • Development of an extensive recombinant drug portfolio in the therapeutic areas of neurodegenerative diseases, fertility, and endocrinology 
  • Achieving a leadership position in therapies for multiple sclerosis and infertility
  • Playing a leading role in international clinical studies and Canadian-based research
  • Offering innovative patient support programs and award-winning patient education material developed in collaboration with leading Canadian experts
  • Proving significant strength in regulatory affairs by surpassing average industry review and approval time through Health Canada
  • Developing a seasoned sales force with a very low turn-over rate and an average of nine years of pharmaceutical industry experience
  • Assisting patients with an in-house bilingual contact centre staffed with customer care specialists, reimbursement experts, and trained nurses to help them better understand their disease, and therapy, or to assist with any reimbursement concerns.
  • Developing award-winning state-of-the-art delivery systems to make administration of medication easier for patients.
 
 

SERVICES